I will have to disagree. The market already expects TKO to do 3+ million this quarter and it has deemed the value at $2.00 per share. What would move it up is something exceeding those expectations. What could move it down is doing something less.
So, I don't see anything moving the stock postive short of incresed guidance or the release of the 200 product. After the CC, I expect neither of these anytime soon.